FI773825A - NYA 7-HALO-3,20-DIOXO-1,4-PREGNADIENER O--4-PREGNENER OCH DERAS FRAMSTAELLNING - Google Patents

NYA 7-HALO-3,20-DIOXO-1,4-PREGNADIENER O--4-PREGNENER OCH DERAS FRAMSTAELLNING

Info

Publication number
FI773825A
FI773825A FI773825A FI773825A FI773825A FI 773825 A FI773825 A FI 773825A FI 773825 A FI773825 A FI 773825A FI 773825 A FI773825 A FI 773825A FI 773825 A FI773825 A FI 773825A
Authority
FI
Finland
Prior art keywords
pregnener
pregnadiener
nya
dioxo
halo
Prior art date
Application number
FI773825A
Other languages
Finnish (fi)
Other versions
FI63947C (en
FI63947B (en
Inventor
Michael J Green
Ho-Jane Shue
Elliot L Shapiro
Margaret A Gentles
Original Assignee
Leitzinger Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/753,257 external-priority patent/US4076708A/en
Application filed by Leitzinger Oy filed Critical Leitzinger Oy
Publication of FI773825A publication Critical patent/FI773825A/en
Application granted granted Critical
Publication of FI63947B publication Critical patent/FI63947B/en
Publication of FI63947C publication Critical patent/FI63947C/en

Links

Classifications

    • E—FIXED CONSTRUCTIONS
    • E04—BUILDING
    • E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
    • E04G11/00—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs
    • E04G11/06—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs for walls, e.g. curved end panels for wall shutterings; filler elements for wall shutterings; shutterings for vertical ducts
    • E04G11/20—Movable forms; Movable forms for moulding cylindrical, conical or hyperbolical structures; Templates serving as forms for positioning blocks or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0084—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkylene group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • E—FIXED CONSTRUCTIONS
    • E04—BUILDING
    • E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
    • E04G17/00—Connecting or other auxiliary members for forms, falsework structures, or shutterings
    • E04G17/14—Bracing or strutting arrangements for formwalls; Devices for aligning forms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Architecture (AREA)
  • Engineering & Computer Science (AREA)
  • Civil Engineering (AREA)
  • Mechanical Engineering (AREA)
  • Structural Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
FI773825A 1976-12-22 1977-12-19 PREPARATION OF THE PHARMACOLOGICAL PROPERTIES OF THE DIFFERENTIAL PREPARATION OF 3,20-DIOXO-7ALFA-HALOGEN-4-PREGNERS FI63947C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US75325676A 1976-12-22 1976-12-22
US75325776 1976-12-22
US05/753,257 US4076708A (en) 1976-12-22 1976-12-22 Process for the preparation of 7α-halogeno-3-oxo-4-dehydro steroids and novel 7α-halogeno derivatives produced thereby
US75325676 1976-12-22

Publications (3)

Publication Number Publication Date
FI773825A true FI773825A (en) 1978-06-23
FI63947B FI63947B (en) 1983-05-31
FI63947C FI63947C (en) 1983-09-12

Family

ID=27115720

Family Applications (1)

Application Number Title Priority Date Filing Date
FI773825A FI63947C (en) 1976-12-22 1977-12-19 PREPARATION OF THE PHARMACOLOGICAL PROPERTIES OF THE DIFFERENTIAL PREPARATION OF 3,20-DIOXO-7ALFA-HALOGEN-4-PREGNERS

Country Status (20)

Country Link
JP (1) JPS604198B2 (en)
AR (1) AR226806A1 (en)
AT (2) AT373269B (en)
BE (1) BE862089A (en)
DE (1) DE2756550C2 (en)
DK (1) DK153494C (en)
FI (1) FI63947C (en)
FR (1) FR2384793A1 (en)
GB (1) GB1575983A (en)
HK (1) HK584A (en)
HU (1) HU179784B (en)
IE (1) IE45950B1 (en)
IL (1) IL53636A (en)
MY (1) MY8500082A (en)
NL (1) NL180479C (en)
NO (1) NO151826C (en)
NZ (1) NZ186031A (en)
PT (1) PT67432B (en)
SE (1) SE429865B (en)
SG (1) SG58683G (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109680036A (en) 2017-10-02 2019-04-26 爱科来株式会社 The measurement of glycated proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429926A (en) * 1964-05-25 1969-02-25 Squibb & Sons Inc 7-halo and 6-halo,6-dehydro a-norprogesterones

Also Published As

Publication number Publication date
BE862089A (en) 1978-06-20
ATA909477A (en) 1983-05-15
IL53636A (en) 1983-05-15
HK584A (en) 1984-01-13
NO151826B (en) 1985-03-04
NL7714056A (en) 1978-06-26
DE2756550C2 (en) 1986-10-16
SE7714538L (en) 1978-06-23
NO774359L (en) 1978-06-23
IE45950B1 (en) 1983-01-12
IE45950L (en) 1978-06-22
NL180479C (en) 1987-03-02
MY8500082A (en) 1985-12-31
GB1575983A (en) 1980-10-01
DK153494B (en) 1988-07-18
DE2756550A1 (en) 1978-07-06
FI63947C (en) 1983-09-12
JPS5379850A (en) 1978-07-14
DK153494C (en) 1989-02-20
PT67432A (en) 1978-01-01
SG58683G (en) 1985-01-11
FR2384793B1 (en) 1981-11-13
IL53636A0 (en) 1978-03-10
FI63947B (en) 1983-05-31
AT377566B (en) 1985-04-10
AT373269B (en) 1984-01-10
HU179784B (en) 1982-12-28
SE429865B (en) 1983-10-03
JPS604198B2 (en) 1985-02-01
PT67432B (en) 1979-05-23
FR2384793A1 (en) 1978-10-20
NO151826C (en) 1985-06-12
NZ186031A (en) 1984-07-31
NL180479B (en) 1986-10-01
DK569977A (en) 1978-09-28
ATA575980A (en) 1982-04-15
AR226806A1 (en) 1982-08-31

Similar Documents

Publication Publication Date Title
FI782607A (en) NYA 3,4,5-TRIHYDROXIPIPERIDINDERIVAT FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING
FI771951A (en) NYA HALOSPORINDERIVAT
FI772778A (en) PORTABLA OCH FOERAENDERLIGA VAEGGSYSTEM
FI773870A (en) HANDSKFOERPACKNING OCH AEMNE FOER DENSAMMA
FI773558A (en) SKEPPSBOTTENFAERG OCH LIKNANDE
FI772823A (en) NYA 1-ARYLOXI-HYDROXI-3-ALKYLENAMINOPROPANER OCH FOERFARANDE FOER DERAS FRAMSTAELLNING
FI773031A (en) HAZLBARA AEGGPRODUKTER OCH FOERFARANDE FOER DERAS FRAMSTAELLNING
SE7707734L (en) NEW HYDROXI-SUCCINIMIDO-ESTRAR
FI773519A (en) FLOTATIONSFOERFARANDE OCH UPPSAMLINGSKOMPOSITION
FI773804A (en) NYA NUCLEOSIDER OCH FOERFARANDE FOER DERAS FRAMSTAELLNING
FI772262A (en) NYA FENYLETYLAMINER OCH FOERFARANDE FOER DERAS FRAMSTAELLNING
FI773219A (en) PROJECT SAERSKILT FOER HANDELVAPEN OCH LAONGPIPIGA VAPEN
FI773801A (en) HYDROXAMSYROR OCH FOERFARANDE FOER DERAS FRAMSTAELLNING
FI773768A (en) LUGGTEXTILFOEREMAOL OCH FOERFARANDE FOER DERAS FRAMSTAELLNING
FI773954A (en) STEROLINER OCH DERAS ANVAENDNING
FI772453A (en) DIHYDRO-OXO-NIKOTINSYROR OCH FOERFARANDE FOER DERAS FRAMSTAELLNING
SE7712387L (en) NEW MORPHANITRIDINES
FI773822A (en) ANTITUMOERGLYKOSIDER OCH FOERFARANDE FOER FRAMSTAELLNING DAERAV
FI772394A (en) NYA BEHENSYRAESTRAR
FI772921A (en) NYA CORTECOIDER
FI773903A (en) NYA BASIS SUBSTITUTE 0-PROPYLOXIMER FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM CEEKEMEDEL
FI772758A (en) HATEROCYCLISM FOR THE FRAMEWORK
FI772833A (en) NYA HYDROXI-METHYL-PYRIDINESTRAR OCH FOERFARANDE FOER DERAS FRAMSTAELLNING
FI772261A (en) NYA ARYL-ALKYLAMINER OCH DERAS FRAMSTAELLNINGSFOERFARANDE
FI783440A (en) NYA ISOKINOLINDERIVAT, DERAS FRAMSTAELLNING OCH DESAMMA INNEHAOLLANDE SAMMANSAETTNINGAR

Legal Events

Date Code Title Description
MA Patent expired
MA Patent expired

Owner name: SCHERING CORPORATION